Price to Earning ratio Analysis of aTyr Pharma Inc - Deep Dive


Latest FY PE
Period Ending - Dec-23

-0.0248


Very Poor PE
Period Ending - Dec-22
-1.25

Very Poor PE
Growth
98.02 %
Trailing Twelve Months PE
Period Ending - Dec-23

-512.96


Very Poor PE
PE Analysis of aTyr Pharma Inc
P/E Ratio -512.96 of aTyr Pharma Inc is negative because of negative EPS.
PE Ratio of LIFE rose handsomely by 98.02 % this year.
PE Ratio with value of -0.0248 was highest in Year Dec-23 in last Five Years.
PE Ratio with value of -1.25 was lowest in Year Dec-22 in last Five Years.
Latest PE Ratio with value of -0.0248 is Greater than Average PE of -0.764 in last five years.
Other PE Related Info of LIFE that may interest you.
aTyr Pharma Inc Overview
CodePricePrevious PricePrice ChangeSector
LIFE2.01.93 3.63 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued.    more ..
Price to Earning Formula

PE Related Ratios
PriceToSalesRatioPriceToBookRatioPriceToCashFlowRatio

Tsr Value Index
Poor Value Stock
FY - Historical Price to Earning of aTyr Pharma Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
PE-0.0248-1.25-1.13-1.13-0.284-0.0089-0.0055
Change98.02 %-10.93 %-0.079 %-297.14 %-3110.44 %-62.18 %-30.75 %
You are view first 7 Records. Log in to view all 14 in Premium view
FY Chart of Price to Earning of aTyr Pharma Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)